APA
Moins N., D'Incan M., Bonafous J., Bacin F., Labarre P., Moreau M., Mestas D., Noirault E., Chossat F., Berthommier E., Papon J., Bayle M., Souteyrand P., Madelmont J. & Veyre A. (20030724). 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. : European journal of nuclear medicine and molecular imaging.
Chicago
Moins Nicole, D'Incan Michel, Bonafous Jacques, Bacin Franck, Labarre Pierre, Moreau Marie-France, Mestas Danièle, Noirault Elisabeth, Chossat Florence, Berthommier Eric, Papon Janine, Bayle Martine, Souteyrand Pierre, Madelmont Jean-Claude and Veyre Annie. 20030724. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. : European journal of nuclear medicine and molecular imaging.
Harvard
Moins N., D'Incan M., Bonafous J., Bacin F., Labarre P., Moreau M., Mestas D., Noirault E., Chossat F., Berthommier E., Papon J., Bayle M., Souteyrand P., Madelmont J. and Veyre A. (20030724). 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. : European journal of nuclear medicine and molecular imaging.
MLA
Moins Nicole, D'Incan Michel, Bonafous Jacques, Bacin Franck, Labarre Pierre, Moreau Marie-France, Mestas Danièle, Noirault Elisabeth, Chossat Florence, Berthommier Eric, Papon Janine, Bayle Martine, Souteyrand Pierre, Madelmont Jean-Claude and Veyre Annie. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. : European journal of nuclear medicine and molecular imaging. 20030724.